Back to search

Article

Time trends in survival and causes of death in multiple myeloma: a population-based study from Germany

2023-01-24

Abstract excerpt

<h4>Background: </h4> Steady evolution of therapies has improved prognosis of patients with multiple myeloma (MM) over the past two decades. Yet, knowledge about survival trends and causes of death in MM might play a crucial role in long-term management of this patient collective. Here, we investigate time trends in myeloma-specific survival at the population level over two decades and analyse causes of death in t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f3962117-d5dc-509e-ade3-b97f12fb9d90
DOI
10.21203/rs.3.rs-2436502/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Time trends in survival and causes of death in multiple myeloma: a population-based study from GermanyDOI 10.21203/rs.3.rs-2436502/v1
Global patterns and trends in multiple myeloma incidence: Age, period and birth cohort analysisSemantic proximity
Second Primary Malignancies Post Autologous Stem-cell Transplant in Multiple Myeloma from India – Knowing the UnknownSemantic proximity
Comparison of Transcriptomic Changes in Younger and Older Multiple Myeloma Patients from the MMRF-CoMMpass Study RNA-Seq DataSemantic proximity
Multiple myeloma: routes to diagnosis, clinical characteristics and survival - findings from a UK population-based study.Semantic proximity
Analysis of long‐term survival in multiple myeloma after first‐line autologous stem cell transplantation: impact of clinical risk factors and sustained responseSemantic proximity
Outcomes of upfront autologous hematopoietic cell transplantation in patients with multiple myeloma who are 75 years old or olderSemantic proximity
Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatmentSemantic proximity
Population-Based Incidence and Mortality Rates of Hematologic Malignancies regarding the Adult Population of Crete, Greece, and Analyses of Their Time Trends and Their Geographical Dis-Tribution: A First Approach from the Cancer Registry of Crete (CRC) for a 22-Year Time Period (1992–2013)Semantic proximity
Identifying Determinants of Survival Disparities in Multiple Myeloma Patients Using Electronic Health Record Data.Semantic proximity
Pattern of Use and Efficacy of Daratumumab-based Therapy in Patients With Multiple Myeloma in a Real-world Setting: a Single Institution ExperienceSemantic proximity
Quantify the Contribution of Modifiable Risk Factors for Progression of MGUS to Multiple MyelomaSemantic proximity
Impact of Daratumumab in Transplant Eligible/Ineligible Patients with Newly Diagnosed Multiple Myeloma: An Updated Meta-Analysis of Phase- III TrialsSemantic proximity
Select a neighboring publication to make it the new centre.